Skip to main content
Cohort 2026-B Simulation • Strict 120-Member Annual Limit

Precision Longevity Architecture. Engineered for the cellular trajectory.

AETERNA delivers bespoke clinical-grade intervention models for leaders requiring peak cognitive stamina, systemic biological age deceleration, and continuous multi-omic optimization.

Explore Protocol Architecture
Swiss Precision Clinical Standards
Continuous Multi-Omic Telemetry
Zero-Knowledge Sovereign Cloud
-4.6 Yrs
Mean Bio-Age Delta
0.74 Pace
DunedinPACE Deceleration
2,400+
Proteomic Biomarkers
Cellular Trajectory Scrubber
INTERACTIVE COHORT
CHRONO: 52.0 YrsBIO-AGE: 45.4 Yrs (-6.6 Yrs Divergence)
M00M06M12M18M24
Sustained Cellular OptimizationDrag slider or click nodes below
Timeline Scrubber:Month 24
M0 (Audit)M06M12M18M24 (Optima)
Phase 04: Longitudinal MaintenanceMonth 24

Stabilized epigenetic aging rate (0.74 yr/yr) and complete restoration of endothelial arterial compliance.

DunedinPACE Aging Rate
0.74 yr/yr
Slowest aging quintile
Systemic hs-CRP
0.3 mg/L
Low vascular inflammation
* Simulated illustrative cohort telemetry. Not an individual patient record or diagnostic medical device.
The Executive Dilemma

Why standard medicine fails the longevity-focused leader.

Conventional healthcare is designed around crisis management and acute triage. Preserving cellular vitality and cognitive bandwidth requires a completely inverted paradigm: continuous proactive biological stewardship.

Dilemma 01 • The Episodic Gap

Annual executive checkups detect failure, not trajectory.

Standard medicine waits for overt pathology. By the time arterial stiffness, glucose intolerance, or neurocognitive slippage cross clinical disease thresholds, decades of sub-cellular deterioration have already occurred.

AETERNA Calibration:Continuous multi-omic telemetry detecting sub-clinical biological inflection points years before diagnostic emergence.
Dilemma 02 • The Wellness Plateau

Generic biohacking lacks clinical dosage and systemic rigor.

Unsupervised supplementation, generic sleep trackers, and fragmented lifestyle advice yield negligible biological age deceleration without precise cellular biomarkers, epigenetic kinetics, and verified clearance protocols.

AETERNA Calibration:Physician-led, targeted senotherapeutic and metabolic architectures calibrated to specific proteomic signatures.
Dilemma 03 • Cognitive Asymmetry

Executive decision-making velocity outpaces neural stamina.

High-velocity founders and managing partners experience cumulative mitochondrial fatigue, sleep fragmentation, and micro-vascular resistance that quietly erode daily cognitive clarity.

AETERNA Calibration:Neuro-vascular fortification through hyperbaric oxygen protocols, cerebral blood-flow profiling, and metabolic substrate support.
Protocol Architecture

Three interconnected clinical pillars.

Every intervention is synchronized across genetic predispositions, real-time blood kinetics, and longitudinal cellular response benchmarks.

01
Molecular Baseline & Epigenetic Blueprint

Multi-Omic Deep Phenotyping

A comprehensive diagnostic baseline synthesizing full-genome sequencing, 2,400+ targeted proteomic plasma markers, organic metabolomics, full-body vascular MRI, and continuous micro-biome telemetry.

Genome Depth60x Whole-Genome
Biological ClocksGrimAge & DunedinPACE
ImagingHigh-Field 3T Full Body MRI
Bi-annual Comprehensive Audit
02
Senolytic Clearance & Telomeric Defense

Cellular & Epigenetic Modulation

Targeted physician-supervised protocols designed to eliminate senescent zombie cells, enhance cellular autophagic turnover, support DNA repair pathways, and modulate DNA methylation patterns.

Cellular TargetSenescent Cell Clearance
Enzymatic PathwaySIRT1 & AMPK Activation
NAD+ Kinetic SupportIntravenous Substrate Delivery
Quarterly Targeted Cycles
03
Mitochondrial Biogenesis & Cerebral Hemodynamics

Neuro-Metabolic Resilience

Optimization of systemic oxygen delivery, micro-vascular elasticity, and neural resilience. Combines hyperbaric protocol series, intermittent hypoxia-hyperoxia therapy (IHHT), and metabolic substrate partitioning.

Oxygen Extraction+18% VO2 Peak
Vascular ElasticityCerebral Perfusion Optimization
Cognitive ReserveExecutive Function Testing
Continuous Adaptive Protocol
Illustrative Prototype Data: All cohort metrics, outcomes, and profiles are simulated modeling representations designed for clinic review and interface evaluation.
Longitudinal Benchmarks

Quantified cellular trajectory modulation.

In clinical simulations, personalized multi-omic protocols demonstrate statistically meaningful divergence from typical accelerated biological aging curves.

EPIGENETIC AGE
-3.8 Yrs
Mean delta over 18 mo cohort
VO2 PEAK CAPACITY
+14.2%
Cardio-respiratory resilience
INFLAMMATION (hs-CRP)
-28.4%
Systemic vascular calm
NEURAL RESTORATION
89.6%
Consistent deep REM efficiency
Illustrative Anonymized Cohort Case Summaries
Cohort Profile 882-Alpha18-Month Continuous Trajectory

52-Year-Old Private Equity Partner

Primary Focus: Vascular Elasticity & Endothelial Restoration

Targeted endothelial nitric-oxide restoration paired with quarterly senolytic clearance resulted in significant reduction of carotid intima-media thickness and complete reversal of pre-diabetic glycemic fluctuations.

Chronological Age
52.4 Yrs
Baseline Epigenetic Age
55.1 Yrs (+2.7)
Month 18 Epigenetic Age
47.9 Yrs (-4.5 vs chrono)
Coronary Calcium & CAC
Zero Progression (Stable)
Cohort Profile 914-Gamma14-Month Continuous Trajectory

46-Year-Old Technology Founder

Primary Focus: Cerebral Perfusion & Deep REM Optimization

Combining intermittent hyperbaric cycles with customized mitochondrial co-enzymes re-anchored autonomic nervous system balance, doubling heart rate variability (HRV) baseline.

Chronological Age
46.1 Yrs
Baseline VO2 Max
38.2 mL/kg/min
Month 14 VO2 Max
47.6 mL/kg/min (+24%)
Deep Sleep Recovery
+52 min / night
Clinical Rigor & Architecture

Frequently Addressed Clinical Inquiries

Understanding our diagnostic methodologies, candidacy prerequisites, and data governance protocols.

We evaluate biological aging using multi-dimensional phenotypic clocks rather than a single biomarker. This integrates DNA methylation sequencing (e.g. DunedinPACE pace of aging and GrimAge mortality predictors), blood proteomic aging algorithms (measuring over 2,400 plasma proteins), coronary arterial calcification velocity, and physiological metrics including micro-vascular endothelial reactivity and heart rate variability (HRV) reserve.

Strict Concierge Cohort Limit

Begin with rigorous baseline phenotyping.

Take proactive command of your biological trajectory. Direct physician liaison reviews each inquiry within 24 hours.

Contact Clinic Concierge
Zurich Flagship • London Mayfair • Geneva • Copenhagen Liaison